|
WO2020165420A1
|
|
Prostate specific membrane antigen (psma) ligands with improved tissue specificity
|
|
WO2017174764A1
|
|
Mathematical model and score for predicting the presence of paroxysmal atrial fibrillation
|
|
WO2017029206A1
|
|
Use of k2p potassium channel for altering the electrophysiology of the heart
|
|
WO2016207363A1
|
|
Combination therapy with a flavagline and 2-deoxyglucose
|
|
WO2016135168A1
|
|
Biomarker panel for the detection of cancer
|
|
EP3207947A1
|
|
Bioactive compound delivery assembly
|
|
EP3189850A1
|
|
Liver targeting of cyclic pres-derived peptides of hbv
|
|
EP3181146A1
|
|
Cyclic ntcp-targeting peptides and their uses as entry inhibitors
|
|
EP3127913A1
|
|
Chromogenic and fluorogenic peptide substrates for the detection of serine protease activity
|
|
EP3118217A1
|
|
Histone anti-cancer vaccines
|
|
EP2801854A1
|
|
Method and apparatus for combination of localization microscopy and structured illumination microscopy
|
|
EP2712542A1
|
|
Structured illumination ophthalmoscope
|
|
EP2265931A1
|
|
A method and an apparatus for localization of single dye molecules in the fluorescent microscopy
|
|
EP2423328A2
|
|
Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells
|
